Francisco A. Moreno, MD

Associate Professor, Psychiatry

AHSC 7306b
P.O. Box 245002
Tucson AZ 85724-5002

Phone: 
(520) 626-6509
Email Address: 
fmoreno@email.arizona.edu
Education: 
  • Universidad Autonoma de Baja California, Escuela de Medicina, 1988 (M.D)
  • University of Arizona, 1992-1996 (Residency, Psychiatry)
  • University of Arizona, 1996-1997 (Fellowship)
Major Areas of Research Interest: 

Dr. Moreno is an Associate Professor of Psychiatry at the University of Arizona College of Medicine. He has been conducting research in the biology and treatment of mood and anxiety disorders, geared to improve our understanding of the brain basis for mental illness and the underlying mechanism of action of antidepressants/antianxiety drugs and treatment resistance. He is also conducting a study evaluating the cost effectiveness of providing treatment through Internet videoconferencing via webcam to compare webcam treatment with standard face-t0-face treatment provided by a primary care provider, thus opening the possibility of delivering telepsychiatric care economically to places that need -but do not have - specialist or culturally appropriate care.

Selected Publications: 

Garriock HA, Allen JJ, Delgado P, Nahaz Z, Kling MA, Carpenter L, Burke M, Burke W, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA. Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Mol Psychiatry. 10(11):976-7, 2005.

Moreno FA, Macey H, Schreiber B. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study. J Clin Psychiatry. 66(5):555-8, 2005.

Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry. 56(6):418-26, 2004.

Opbroek A, Delgado PL, Laukes C, McGahuey C, Katsanis J, Moreno FA, Manber R. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? Int J Neuropsychopharmacol. 5(2):147-51, 2002.

Sponsored Research Through MSRP: 

Justin Tolman (MSRP 2004): "Association between the 5-HT6 receptor polymorphism C267T and mood response during tryptophan depletion."

Lisa Goldman (MSRP 2005): "Pharmacogenetics of depression: A candidate gene associate study of treatment response based phenotypes."

Heather Streich (MSRP 2008): "An assessment of the frequency of the FKBP5-Gene in people with treatment-resistant and treatmen-responsive depression."

Crysta Clemente (MSRP 2009): "Hallucinogenic effects and dose response of psilocybin."

NIH High School Student Research Program: 

-Krystle Hall, Tucson Magnet High School, 2003
-Iris Alfaro, Pueblo High School, 2006

-Jennifer Villalobos, Kofa High School, 2007

Last Updated: 
May 18, 2012